In the case of the bridging study, small differences observed between the low- and high-dose regimens did not reach statistical significance (Supplementary Table 5a available online at http://informahealthcare.com/doi/abs/10.3109/14397595.2014.914014 ).
← all excerpts
Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials.
1
—
—